Literature DB >> 22654086

An earlier and more confident diagnosis of idiopathic pulmonary fibrosis.

Roland M du Bois1.   

Abstract

A diagnosis of idiopathic pulmonary fibrosis (IPF) has serious implications for the affected individuals, who have a 50% likelihood of dying within 2-3 yrs, an outcome which is worse than many cancers. A swift and accurate diagnosis is imperative, especially as commencing treatment at a relatively early disease stage may have the greatest impact on reducing disease progression. The 2011, IPF guidelines provide updated and simplified IPF diagnostic criteria that may facilitate making a more confident diagnosis. The key investigational tool is high-resolution computed tomography (HRCT). In the presence of the four classical features, that together accurately identify a usual interstitial pneumonia (UIP) pattern, a definitive diagnosis of IPF can be made. When HRCT honeycombing is absent, even in the presence of all other features including traction bronchiectasis, the guidelines provide no designation for this constellation of features that many clinicians and radiologists would regard as consistent with UIP. The diagnostic algorithm suggested by the 2011 guidelines emphasises the importance of multidisciplinary discussion between clinicians, radiologists and pathologists to improve diagnostic confidence. The course of disease in IPF is unpredictable, but the importance of an early diagnosis is clear, as individuals with less severe lung function abnormalities have a better prognosis.

Entities:  

Mesh:

Year:  2012        PMID: 22654086     DOI: 10.1183/09059180.00000812

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  32 in total

1.  Clusterization of patients with idiopathic pulmonary fibrosis with chemokine receptors: a possible role in the diagnostic work-up of idiopathic pulmonary fibrosis?

Authors:  Giuseppe Brunetti; Alberto Malovini; Claudia Testoni; Riccardo Bellazzi; Antonella Balestrino; Antonio Meriggi; Gianna Moscato; Arnaldo Alessandrini; Federica Rivolta; Patrizia Pignatti
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  Idiopathic pulmonary fibrosis complicated by acute thromboembolic disease: chest X-ray, HRCT and multi-detector row CT angiographic findings.

Authors:  Luigi Camera; Francesco Campanile; Massimo Imbriaco; Renato Ippolito; Cesare Sirignano; Ciro Santoro; Maurizio Galderisi; Marco Salvatore
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

3.  [Therapeutic relevance of HRCT findings from a pneumological viewpoint].

Authors:  R Suchy; M Pfeifer
Journal:  Radiologe       Date:  2014-12       Impact factor: 0.635

Review 4.  Diagnosis of idiopathic pulmonary fibrosis: Current issues.

Authors:  Rajendra Prasad; Nikhil Gupta; Abhijeet Singh; Pawan Gupta
Journal:  Intractable Rare Dis Res       Date:  2015-05

5.  Diagnostic disparity of previous and revised American Thoracic Society guidelines for idiopathic pulmonary fibrosis.

Authors:  Lee Fidler; Shane Shapera; Shikha Mittoo; Theodore K Marras
Journal:  Can Respir J       Date:  2015-01-09       Impact factor: 2.409

Review 6.  The diagnosis and treatment of idiopathic pulmonary fibrosis.

Authors:  Jürgen Behr
Journal:  Dtsch Arztebl Int       Date:  2013-12-23       Impact factor: 5.594

7.  Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges.

Authors:  Paolo Spagnolo; Roberto Tonelli; Elisabetta Cocconcelli; Alessandro Stefani; Luca Richeldi
Journal:  Multidiscip Respir Med       Date:  2012-11-12

8.  Patients with Terminal Interstitial Pneumonia Require Comparable or More Palliative Pharmacotherapy for Refractory Dyspnea than Patients with Terminal Lung Cancer.

Authors:  Hiroko Okabayashi; Hideya Kitamura; Satoshi Ikeda; Akimasa Sekine; Tsuneyuki Oda; Tomohisa Baba; Eri Hagiwara; Takuro Sakagami; Takashi Ogura
Journal:  Palliat Med Rep       Date:  2021-06-16

Review 9.  State of the art in the diagnosis and management of interstitial lung disease.

Authors:  Maria T A Buzan; Carmen Monica Pop
Journal:  Clujul Med       Date:  2015-04-15

10.  Inhibition of fibrosis and inflammation by triple therapy with pirfenidone, edaravone and erythropoietin in rabbits with drug-induced lung injury: comparison of CT imaging and pathological findings.

Authors:  Shobu Watanabe; Norihisa Nitta; Akinaga Sonoda; Ayumi Nitta-Seko; Shinichi Ohta; Keiko Tsuchiya; Hideji Otani; Yuki Tomozawa; Yukihiro Nagatani; Kenichi Mukaisho; Masashi Takahashi; Kiyoshi Murata
Journal:  Exp Ther Med       Date:  2013-09-18       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.